Arthur T. Sands
President, CEO, Director · Nurix Therapeutics, Inc.
Individual
- 2026
- Feb 10, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arthur T. Sands files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Ring - $3.33M in NRIX purchases and sales in the last 12 months
- Houte Hans van - $635K in NRIX purchases and sales in the last 12 months
- Gwenn Hansen - $522K in NRIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arthur T. Sands?
Arthur T. Sands is a corporate insider, tracked as President, CEO, Director of Nurix Therapeutics, Inc. (NRIX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Arthur T. Sands last file a Form 4?
The only primary Form 4 on record is dated 10 February 2026.